{"data":[{"accessionNo":"0001140361-26-019395","formType":"SCHEDULE 13D/A","amendmentNo":1,"issuerCik":"0001124105","issuerName":"Gyre Therapeutics, Inc.","ticker":"GYRE","cusip":"403783103","securityClass":"Common Stock, par value $0.001 per share","eventDate":"2026-05-04","reportingPerson":"Songjiang Ma","reportingCik":"0001985547","personType":"IN","sharesOwned":7342131,"percentOfClass":6.33,"filedAt":"2026-05-07","canonicalUrl":"https://xoomar.com/markets/stocks/gyre"},{"accessionNo":"0001140361-26-019395","formType":"SCHEDULE 13D/A","amendmentNo":1,"issuerCik":"0001124105","issuerName":"Gyre Therapeutics, Inc.","ticker":"GYRE","cusip":"403783103","securityClass":"Common Stock, par value $0.001 per share","eventDate":"2026-05-04","reportingPerson":"Yueying Zhu","reportingCik":null,"personType":"IN","sharesOwned":7342131,"percentOfClass":6.33,"filedAt":"2026-05-07","canonicalUrl":"https://xoomar.com/markets/stocks/gyre"},{"accessionNo":"0001140361-26-019380","formType":"SCHEDULE 13D/A","amendmentNo":5,"issuerCik":"0001124105","issuerName":"Gyre Therapeutics, Inc.","ticker":"GYRE","cusip":"403783103","securityClass":"Common Stock, par value $0.001 per share","eventDate":"2026-05-04","reportingPerson":"GNI USA, Inc.","reportingCik":null,"personType":"CO","sharesOwned":86323015,"percentOfClass":69.1,"filedAt":"2026-05-06","canonicalUrl":"https://xoomar.com/markets/stocks/gyre"},{"accessionNo":"0001140361-26-019380","formType":"SCHEDULE 13D/A","amendmentNo":5,"issuerCik":"0001124105","issuerName":"Gyre Therapeutics, Inc.","ticker":"GYRE","cusip":"403783103","securityClass":"Common Stock, par value $0.001 per share","eventDate":"2026-05-04","reportingPerson":"GNI Group Ltd.","reportingCik":"0001958461","personType":"CO","sharesOwned":86323015,"percentOfClass":69.1,"filedAt":"2026-05-06","canonicalUrl":"https://xoomar.com/markets/stocks/gyre"},{"accessionNo":"0001140361-26-019388","formType":"SCHEDULE 13D/A","amendmentNo":1,"issuerCik":"0001124105","issuerName":"Gyre Therapeutics, Inc.","ticker":"GYRE","cusip":"403783103","securityClass":"Common Stock, par value $0.001 per share","eventDate":"2026-05-04","reportingPerson":"Ying Luo","reportingCik":"0001959160","personType":"IN","sharesOwned":10211387,"percentOfClass":8.6,"filedAt":"2026-05-06","canonicalUrl":"https://xoomar.com/markets/stocks/gyre"},{"accessionNo":"0001140361-26-019388","formType":"SCHEDULE 13D/A","amendmentNo":1,"issuerCik":"0001124105","issuerName":"Gyre Therapeutics, Inc.","ticker":"GYRE","cusip":"403783103","securityClass":"Common Stock, par value $0.001 per share","eventDate":"2026-05-04","reportingPerson":"Ping Lan","reportingCik":null,"personType":"IN","sharesOwned":10211387,"percentOfClass":8.6,"filedAt":"2026-05-06","canonicalUrl":"https://xoomar.com/markets/stocks/gyre"}],"updatedAt":"2026-11-04T05:21:55.037Z","source":"xoomar.com","docs":"https://xoomar.com/markets/api","license":"https://xoomar.com/terms","attribution":"Credit XOOMAR with a link to the dataset page on xoomar.com when you republish this data","canonicalUrl":"https://xoomar.com/markets/stocks/gyre","meta":{"source":"SEC","sourceAttribution":"Schedule 13D and 13G data: SEC.","notice":"10 requests a minute without a key, 30 with a free key. Get a free key at https://xoomar.com/signup?utm_source=api, register your app at https://xoomar.com/developers/register?utm_source=api, and credit the data as \"Data: XOOMAR\" together with the sourceAttribution line."}}